1
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:April 27, 2023Recruiting
Fludarabine: 2098 Clinical Trials, Page 1 of 210
Hide Studies Not Open or Pending
2
A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies
Condition(s):Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic SyndromesLast Updated:June 28, 2023Recruiting
3
Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
Condition(s):MyelomaLast Updated:December 28, 2021Not yet recruiting
4
Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation
Condition(s):Acute Leukemia; Chronic Leukemia; Severe Aplastic AnemiaLast Updated:August 20, 2014Unknown status
5
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition(s):B-Cell Chronic Lymphocytic Leukemia; B-Lymphocytic Leukemia, Chronic; Chronic Lymphocytic Leukemia; Leukemia, Chronic Lymphatic; Leukemia, Chronic Lymphocytic, B-Cell; Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytic Leukemia, Chronic, B Cell; Lymphocytic Leukemia, Chronic, B-CellLast Updated:April 19, 2023Active, not recruiting
6
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Condition(s):Hematologic MalignancyLast Updated:June 26, 2018Withdrawn
7
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
Condition(s):Acute Myeloid Leukemia, Adult; AML; AML, AdultLast Updated:September 22, 2022Terminated
8
A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:March 24, 2023Active, not recruiting
9
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromesLast Updated:August 15, 2023Active, not recruiting
10
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
Condition(s):Acute Myeloid Leukemia; Core-Binding FactorLast Updated:May 11, 2022Recruiting